Motion Sickness Relief Tablet, Chewable
Product Images NDC 51013-322

2 FDA label images from Puracap Pharmaceutical Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Motion Sickness Relief (NDC 51013-322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puracap Pharmaceutical Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cvsb36-00 (Cvsb36 00)

Cvsb36-00 (Cvsb36 00)
Drug facts and directions panel for Motion Sickness Relief (Meclizine HCl) chewable tablets 25 mg. Includes warnings about drowsiness and alcohol use, directions for dosing, phenylketonurics information, storage conditions, inactive ingredients, and a contact phone number for questions or comments. Emphasizes consulting a doctor if pregnant or breast-feeding and keeping out of reach of children.*
FDA Label Image

Cvsf36-00 (Cvsf36 00)

Cvsf36-00 (Cvsf36 00)
Drug Facts panel for Motion Sickness Relief chewable tablets containing Meclizine HCl 25 mg. The label indicates it helps prevent nausea, dizziness, and vomiting related to motion sickness. It lists warnings, usage conditions, and advises consulting a doctor under specific health concerns or for children under 12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.